Topic Hub

Ethnicity Rapamycin

3 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

3articles

24keywords mapped

2024-09-01latest review

Explore

Ethnicity Rapamycin library

Showing 3 of 3 clinical reviews.

Safety2024-09-01

Rapamycin (Sirolimus) Hispanic / Latino Safety Profile Differences

A clinician-reviewed guide to sirolimus pharmacogenomics, dosing, and safety considerations specific to Hispanic and Latino patients, covering CYP3A5 variants, diabetes risk, dyslipidemia, and ethnicity-stratified trial data.

Read clinical review

Dosing & Monitoring2026-05-27

Rapamycin (Sirolimus) in South Asian Patients: Documented Efficacy Gaps and Dosing Considerations

Evidence-based review of how rapamycin (sirolimus) performs differently in South Asian populations, covering pharmacogenomics, CYP3A5 polymorphisms, metabolic context, and dosing adjustments.

Read clinical review

Safety2025-01-28

Rapamycin (Sirolimus) South Asian Safety Profile Differences

South Asian patients face distinct pharmacogenomic and metabolic risks with sirolimus. Learn how CYP3A5 expression, baseline insulin resistance, and cardiovascular risk at lower BMI affect dosing, monitoring, and safety thresholds for rapamycin in this population.

Read clinical review